Ventricular Tachycardia Recurrence, Hospitalization and Death Reduced With Catheter Ablation as First Line Therapy. Results from an international clinical trial show a significant reduction in risk of ventricular tachycardia (VT) recurrence, cardiovascular hospitalization, and sudden cardiac death (SCD) death when catheter ablation is used as an early first-line treatment for patients with structural heart disease. Led by study coordinating center, the University of Chicago, The PAUSE-SCD trial. #HRS21
August 09, 2021
Ventricular Tachycardia Recurrence, Hospitalization and Death Reduced With Catheter Ablation as First Line Therapy
August 9, 2021 – Results from an international clinical trial show a significant reduction in risk of ventricular…
Read More
The Adagio Medical iCLAS cryoablation system is commercial in Europe and is also part of an ongoing FDA IDE trial in the U.S. #HRS21
August 09, 2021
Pulsed Field Cryoablation Eliminated AF in 85% After Single Ablation Procedure
August 9, 2021 — Adagio Medical Inc., a provider of catheter ablation technologies for atrial fibrillation (AF) and…
Read More
Heart Rhythm Society, HRS, 2021 Late-Breaking Clinical Trials in Electrophysiology. #HRS #HRS2021 #HRS21 #Heartrhythm21
August 09, 2021
Heart Rhythm Society 2021 Late-Breaking Clinical Trials in Electrophysiology
July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them…
Read More
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death
August 09, 2021
Boston Scientific Recalls INGENIO Family of Pacemakers
August 9, 2021 — Boston Scientific is recalling INGENIO family of pacemakers and CRT-Ps due to the risk of incorrect…
Read More
An example from the study of the Biosense Webster NuVision 3D/4D ICE imaging capability showing the left atrial appendage (LAA) visualization on 3D ICE. The system allows the user to place a false lighting source to be placed in different positions to change the lighting and shadows to better visualize the anatomy.
By Dave Fornell, Editor
August 05, 2021
First-in-Human Experience With Novel 4D ICE Catheter For Catheter Ablation and LAA Closure Procedures
August 5, 2021 —  A prospective, non-randomized, multicenter, first-in-human clinical study found good diagnostic and…
Read More
Abbott's new interventional imaging platform powered by Ultreon 1.0 Software is a first-of-its-kind imaging software merges optical coherence tomography (OCT) intravascular imaging with the power of artificial intelligence (AI) for enhanced visualization. The new Ultreon Software can automatically detect the severity of calcium-based blockages and measure vessel diameter to enhance the precision of physicians’ decision-making during coronary stenting procedures.
August 05, 2021
FDA Clears Abbott OCT Imaging Enhanced With Artificial Intelligence
August 5, 2021 — The U.S. Food and Drug Administration (FDA) has cleared clearance Abbott's latest optical coherence…
Read More
EP lab ablation catheter. #HRS21 #HRS2021
August 03, 2021
Patients With Atrial Fibrillation and Heart Failure Benefit From Early Rhythm Control
August 3, 2021 — A subgroup analysis of the EAST – AFNET 4 study population revealed early initiation of rhythm control…
Read More
emporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation (AF) after coronary artery bypass (CAGB) surgery CABG without any adverse events in a randomized pilot study. The TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery (TerminationAF) study was presented as a late-breaking study presented at the 2021 Heart Rhythm meeting, the annual conference of the Heart Rhythm Society (HRS).  #HRS21 #HRS2021
August 03, 2021
Spinal Cord Stimulation Helps Suppress AF in CABG Patients
August 4, 2021 — Temporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial…
Read More
Oral Contraceptives Cause Increased Risk of Cardiac Events in Woman With Long QT Syndrome. #HRS21 #HRS2021 #womenshealth
August 03, 2021
Oral Contraceptives Cause Increased Risk of Cardiac Events in Woman With Long QT Syndrome
August 3, 2021 – Results from a new clinical trial show an increased risk of cardiac events, like sudden cardiac death…
Read More
A recent study unveiled a novel sinus node ablation technique that provides a safe and effective treatment option for patients suffering from symptomatic, drug-resistant inappropriate sinus tachycardia (IST). Results of the Susruta-IST Registry were presented as a late-breaking clinical trial at Heart Rhythm 2021, the annual meeting of the Heart Rhythm Society (HRS). #HRS21 #HRS2021
August 03, 2021
New Hybrid Ablation Technique Safe and Effective Treatment for Patients With Inappropriate Sinus Tachycardia
August 3, 2021 – A recent study unveiled a novel sinus node ablation technique that provides a safe and effective…
Read More
The Philips EPD Kodex system for the EP lab.
August 03, 2021
Economic Analysis of CABANA Trial Reveals Economic Benefits of Catheter Ablation Compared to Drug Therapy
August 3, 2021 – A new analysis of the Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation (…
Read More
The new Octaray high-density mapping catheter from Biosense Webster has 48 electrodes to enable faster and more detailed electromapping of the heart to better guide ablation procedures.
August 03, 2021
Biosense Webster Showcases New Data and Latest Innovations at Heart Rhythm 2021
August 3, 2021 – Biosense Webster, the global leader in cardiac arrhythmia treatment and part of Johnson & Johnson…
Read More
BIO-AffectDX is a multi-center, observational study that will enroll HF patients with paroxysmal, persistent and long-standing persistent AF, and a standard CRT-D indication. The study will include up to 400 participants implanted with a Biotronik Acticor CRT-DX system.
August 03, 2021
New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients With Atrial Fibrillation
August 3, 2021 — In association with Heart Rhythm 2021, Biotronik announced first enrollments in the landmark BIO-…
Read More
The Orchestra BioMed BackBeat Cardiac Neuromodulation Therapy (CNT) system is implanted similar to a pacemaker to stimulate the sympathetic nerves to help reduce blood pressure.
August 03, 2021
Significant and Sustained Reduction in Blood Pressure in MODERATO II Trial Using BackBeat Cardiac Neuromodulation Therapy in Crossover Patients
August 3, 2021 — Long-term follow-up data on hypertensive patients from the control group of the MODERATO II study who…
Read More
In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. ACC, HRS, ASNC, SCMR, SCCT, ASE, HFSA, STS, SCAI.
By Dave Fornell, Editor
July 30, 2021
Cardiovascular Societies Support COVID-19 Vaccines for all Healthcare Workers 
July 30, 2021 — A coalition of 10 U.S.-based cardiovascular societies have issued a statement today in support of all…
Read More
Innovative Health Inc. announced several new initiatives to increase savings from single-use device reprocessing in the electrophysiology (EP) lab. #HRS21 #HRS2021 #Heartrhythm21
July 30, 2021
Innovative Health Planning to Add Catheter Reprocessing for  Emerging EP Technologies 
July 30, 2021 – Innovative Health Inc. announced several new initiatives to increase savings from single-use device…
Read More
Results of the STROKE-VT trial showed direct oral anticoagulants (DOACs) are more effective than aspirin in reducing cerebrovascular events, including stroke in patients undergoing ventricular tachycardia ablation.
July 29, 2021
Oral Anticoagulants After Catheter Ablation Helps Reduce Stroke in High-Risk Patients
July 29, 2021 – Results of the STROKE-VT trial shows direct oral anticoagulants (DOACs) are more effective than aspirin…
Read More
The devices compared in the study were the Bardy Carnation Ambulatory Monitor long-term continuous ECG system (left) and the BioGuardian MCT cardiac event monitor (right).  #HRS21 #HRS2021 #HeartRhythm21
July 29, 2021
Human ECG Monitoring Outperforms AI Dependent Remote Cardiac Monitoring
July 29, 2021 – Results from a new clinical trial found human-oversight dependent continuous electrocardiography (ECG)…
Read More
The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 
July 29, 2021
Bardy Carnation Ambulatory Monitor Patch Decreases Diagnosis Time and Readmissions
July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation…
Read More
St. Jude Medical Pays $27 Million for Allegedly Selling Defective ICD and CRT-D devices
July 28, 2021
St. Jude Medical Pays $27 Million for Allegedly Selling Defective Heart Devices
July 28, 2021 — The U.S. Justice Department announced earlier this month that St. Jude Medical Inc. agreed to pay $27…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now